References
1. Vinh DC, Sugui JA, Hsu AP, Freeman AF, Holland SM. Invasive fungal
disease in autosomal-dominant hyper-IgE syndrome. The Journal of allergy
and clinical immunology. 2010;125(6):1389.
2. Schimke LF, Sawalle-Belohradsky J, Roesler J, Wollenberg A, Rack A,
Borte M, et al. Diagnostic approach to the hyper-IgE syndromes:
immunologic and clinical key findings to differentiate hyper-IgE
syndromes from atopic dermatitis. Journal of allergy and clinical
immunology. 2010;126(3):611-7. e1.
3. Cruz‐Portelles A, Estopiñan‐Zuñiga D. A new case of Job’s syndrome at
the clinic: A diagnostic challenge. Revista Portuguesa de Pneumologia
(English Edition). 2014;20(2):107-10.
4. Fabre A, Marchal S, Barlogis V, Mari B, Barbry P, Rohrlich PS, et al.
Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A
Systematic Review. J Allergy Clin Immunol Pract. 2019;7(6):1958-69.e9.
5. Fabre A, Marchal S, Barlogis V, Mari B, Barbry P, Rohrlich P-S, et
al. Clinical aspects of STAT3 gain-of-function germline mutations: a
systematic review. The Journal of Allergy and Clinical Immunology: In
Practice. 2019;7(6):1958-69. e9.
6. Esposito L, Poletti L, Maspero C, Porro A, Pietrogrande MC, Pavesi P,
et al. Hyper-IgE syndrome: dental implications. Oral surgery, oral
medicine, oral pathology and oral radiology. 2012;114(2):147-53.
7. Yong PF, Freeman AF, Engelhardt KR, Holland S, Puck JM, Grimbacher B.
An update on the hyper-IgE syndromes. Arthritis research & therapy.
2012;14(6):1-10.
8. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, et al. IL-22
mediates mucosal host defense against Gram-negative bacterial pneumonia.
Nature medicine. 2008;14(3):275.
9. Avery DT, Ma CS, Bryant VL, Santner-Nanan B, Nanan R, Wong M, et al.
STAT3 is required for IL-21–induced secretion of IgE from human naive B
cells. Blood. 2008;112(5):1784-93.
10. Motedayyen H, Ghotloo S, Saffari M, Sattari M, Amid R. Evaluation of
microRNA‐146a and its targets in gingival tissues of patients with
chronic periodontitis. Journal of periodontology. 2015;86(12):1380-5.
11. Ghotloo S, Motedayyen H, Amani D, Saffari M, Sattari M. Assessment
of micro RNA‐146a in generalized aggressive periodontitis and its
association with disease severity. Journal of periodontal research.
2019;54(1):27-32.
12. Renner ED, Rylaarsdam S, Aňover-Sombke S, Rack AL, Reichenbach J,
Carey JC, et al. Novel STAT3 mutations, reduced TH17 cell numbers, and
variably defective STAT3 phosphorylation in Hyper-IgE syndrome. The
Journal of allergy and clinical immunology. 2008;122(1):181.
13. Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech
HL, et al. Hyper-IgE syndrome with recurrent infections—an autosomal
dominant multisystem disorder. New England Journal of Medicine.
1999;340(9):692-702.
14. O’Connell AC, Puck JM, Grimbacher B, Facchetti F, Majorana A, Gallin
JI, et al. Delayed eruption of permanent teeth in
hyperimmunoglobulinemia E recurrent infection syndrome. Oral Surgery,
Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology.
2000;89(2):177-85.
15. Domingo D, Freeman A, Davis J, Puck J, Tianxia W, Holland S, et al.
Novel intraoral phenotypes in hyperimmunoglobulin‐E syndrome. Oral
diseases. 2008;14(1):73-81.
16. Wjst M, Lichtner P, Meitinger T, Grimbacher B. STAT3
single-nucleotide polymorphisms and STAT3 mutations associated with
hyper-IgE syndrome are not responsible for increased serum IgE serum
levels in asthma families. European Journal of Human Genetics.
2009;17(3):352.
17. Saeedfar K, Behmanesh M, Mortaz E, Masjedi MR. The Expression of
STAT3 and STAT5A Genes in Severe Refractory Asthma. Tanaffos.
2017;16(1):1.